Latest News
US FDA approves Mesoblast’s cell therapy for graft-versus-host disease
(Reuters) – The U.S. Food and Drug Administration on Wednesday approved Mesoblast (NASDAQ:MESO)’s cell therapy for treating a type of...
Read more
ANZ’s outgoing CEO to forfeit 2024 long-term variable remuneration
(Reuters) – ANZ Group’s CEO Shayne Elliott will not be taking the 2024 long-term variable remuneration after a large proportion...
Read more
Weedmaps co-founders propose to take company private
IRVINE, Calif. – The co-founders of WM Technology, Inc., better known as Weedmaps, have approached the company’s board with a...
Read more
US healthcare spending neared $5 trillion in 2023, government report says
By Amina Niasse NEW YORK (Reuters) -U.S. healthcare spending rose by 7.5% to $4.9 trillion in 2023, driven by increased...
Read more
Tesla, Broadcom lead tech stock crash as Fed eyes fewer rate cuts in 2025
Tesla (NASDAQ:TSLA) shares tumbled 8.3% Wednesday as U.S. stocks fell broadly in response to the Federal Reserve’s latest policy commentary....
Read more
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.58%
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Consumer Goods, Financials and Consumer...
Read more
US requests USMCA dispute settlement talks with Mexico on labor issues
WASHINGTON (Reuters) – The U.S. said on Wednesday it has requested the establishment of dispute settlement panels under the U.S.-Mexico-Canada...
Read more
Colombia stocks lower at close of trade; COLCAP down 0.53%
Investing.com – Colombia stocks were lower after the close on Wednesday, as losses in the Financials, Investment and Public Services...
Read more
